Rizgar Saltik

Engineers from Achmea, the biggest Dutch insurance company and Achmea Foundation have joined FruitPunch AI & GOAL 3 to help save millions of child lives in Sub-Saharan Africa 🎉 In our Challenge 'AI against Infant Death' we're helping GOAL 3 add ML capabilities to their life-saving medical devices 🙏 (as pictured below) This collaboration with Achmea to have their engineers apply their skills in our AI for Good Challenges is a huge step in our mission to get 🔥 1M engineers use their skills for good 🔥 Working with enterprizes is (next to our amazing Expert volunteer community!) the future of FruitPunch AI because it allows us to both fund our Challenges ánd source engineers, who in turn receive applied AI education and a motivating change of pace. Achmea published about the collaboration here: https://lnkd.in/e8bH_5dJ This is another step in becoming a completely self-sustaining, scalable platform for the application and education of AI for Good - I believe one of the most pressing challenges of our time. ✅ You can still join the Challenge / find more info here: https://lnkd.in/eeANUhcC Thanks to the people within Achmea & Foundation pushing for this, and of course the team of Goal 3, honored to help out: Agnes Arnoud Niek Jelle Erwin Arjan Lonneke Fleur ❤️

130

8 commentaren

“The Mystery of the Digits: Sensitech’s Dirty Secret Hidden in TempTale Serial Numbers” We believe the public deserves transparency, so today we’re sharing a critical document called the TTRecycle sheet—a file sent to us by Joost van Bohemen, an ex-board member #Sensitech EMEA BV. According to Joost’s testimony under oath at Rechtbank Den Haag this document is NOT confidential. This TTRecycle sheet illustrates Sensitech’s questionable practices regarding #TempTale devices, specifically used/ recycled, non-validated TempTales that cannot be traced or verified during #audits, jeopardizing compliance in #food, #pharma and US Army #coldchain & #supplychain Here’s what we’ve uncovered: • If you’re using a TempTale4 Single Use device, look for a 4th digit of 8 or 9 to identify a recycled unit. • For a TT4USB Single Use, watch for the last 5 digits between 27000-35000 to spot a reused device. • The first 3 digits reveal the production date, giving insight into how old your TempTale really is. Here’s the kicker: When we pressed Matt Mathai, a senior Sensitech figure, for clarity on these used/recycled devices, his response was astounding. Matt declared, “The production date is #proprietary and will not be shared outside of the company.” Yes, you read that right: Sensitech considers the production date of YOUR purchased TempTale “proprietary information.” When pressed further, Matt doubled down with hostility, replying in angry red font, as if that would silence us. Industries relying on these devices—food, life sciences, and even the U.S. military supply chain—deserve better than recycled, untraceable devices hidden behind secrecy. And while #Halloween has passed, at Sensitech, it’s still trick or treat. You order a TempTale for your cold chain operations, expecting the quality promised in Sensitech’s datasheets and #QMS. Instead, you might receive a recycled, non-validated device, unreliable for audits or critical shipments. This isn’t just poor customer service—it’s about accountability. TempTales are critical tools for protecting public health and safety. If Sensitech is this secretive, the question isn’t just what they’re hiding, but why. Should companies like Sensitech, a Carrier Commercial Refrigeration subsidiary face scrutiny for these practices? While the cold chain industry stakeholders remains silent—who will step up and break it?” At least let’s discuss. #MilitarySupplyChain #FoodSafety #LifeSciences #SupplyChainRisks #CorporateAccountability #AuditCompliance #BusinessEthics #PublicHealth #SpeakUp #WhistleBlowerProtection #FraudAwareness #ProductionDate #ProductionCertificate #OpenDiscussion #Debate #Pharmaceuticals

2

1 commentaar

Sensitech & Carrier Commercial Refrigeration employees at Ethical Crossroads : Will You Stand for Integrity or Stay Silent? At Sensitech, some employees and most of management seem to treat selling used, recycled, and non-validated #TempTale devices as if it’s entirely normal. Yet, the company’s leadership consistently denies the existence of the TTRecycle practice—a denial that should raise serious questions about what your company is really up to. If that doesn’t make you suspicious, it should. In light of this, you’re left with two clear choices—and a third, more troubling reality: • Do the Right Thing Report these practices based on your Code of Ethics Speak Up platform. Acknowledge that what’s happening is far from transparent, ethical, or aligned with industry standards. Choose to #SpeakUp for #integrity and accountability. • Turn a Blind Eye Ignore the problem. Remain #Silent Collect your paycheck, chase that bonus, and enjoy your weekends. Maybe you don’t care about the industry or the impact of selling questionable devices. But ask yourself—is this really the legacy you want to leave behind? • The Troubling Reality  For those unfamiliar with my story, check my previous posts when you have the time. Under David Gitlin’s “leadership” #whistleblowers like my wife Wendy and me have faced relentless retaliations, lawsuits, violations of our First Amendment rights, threats, harassment, financial ruin, and isolation—all for reporting in accordance with Carrier's Code of Ethics, by exposing Sensitech's fraud and corruption. If you’re an employee wondering about Gitlin’s commitment of “no retaliation”, take it from us: they’re as empty as the ethics he claims to uphold. Sensitech and Carrier have already shown they will weaponize the legal system against anyone daring to speak up. So, which is it? Will you stay complicit, silent, ignoring the damage to industry integrity and customer trust, or will you stand up for the integrity of the cold chain and the industries that depend on it? The choice is yours. Please don’t ignore my previous advise: Lawyer up before you Speak Up ! #WhistleblowerProtection #LawyerUpBeforeYouSpeakUp #PublicHealthMatters #CorporateAccountability #EthicsInBusiness #SpeakUp #LawyerUP #FraudAwareness #ISOCompliance #CorporateGovernance #Malfeasance #Pharmaceuticals #FoodSupplyChain #ColdChain #Integrity #Leadership #RiskManagement NAVEX

2

💠 💠 xQlaim B.V. official launch! 💠 💠   Loaded with great memories and experiences, I am pleased to announce the launch of xQlaim B.V. ✨ xQlaim is a consultancy company supporting innovative MedTechs (start-ups, scale-ups or larger corporate) define their products & services strategy using Medical Device Claim Management as a thread line throughout the innovation process. Healthcare innovation is almost never easy, due to its complexity in a highly regulated environment. For any company, getting it first-time-right (or as close as possible), is known to save time, money and effort. My learning for the last 18+ years in corporate R&D, is that Claim Management is key to the innovation success:  ➡  It helps define the innovation strategy at an early stage: from market needs, positioning against competitors, business viability, technology requirements. ➡  It helps anticipate, as early as possible, feasibility, timelines and costs, in the very complex environment of regulated medical devices. ➡  It is key to market a product. ➡  It is a requirement for medical device certification (FDA and EU-MDR). At xQlaim B.V., we would like to guide and support healthcare innovating companies who need it, to solve one or more of the following key identified challenges: ✨ Get a strong understanding of user and customer needs ✨ Define a competitive positioning in the market to solve these ✨ Select meaningful and realistic medical product claims and their Roadmap to achieve it ✨ Advise on (clinical) evidence creation strategy. ✨ Support the documentation of the claims for regulatory compliance. Our consultancy services have been designed to: ✅ Help align all competences key to the claim management process (Business development, marketing, technology, clinical, regulatory, legal), making use of high performing team principles in the process. ✅ Enable clear and data-driven decision making. ✅ Enable different types of service provision: facilitation, advisory and/or hands-on work. You will soon be able to find more information on our website and our LinkedIn company page (xQlaim B.V.). And feel free to contact me directly via DM, if you want to learn more or see opportunities to collaborate. 🙏 I would like to thank all the people who supported me the last few months to get xQlaim off the ground. Your formal and/or informal mentoring have been invaluable to me. Whether it was to help me find a brand, to challenge me or to simply say “you can do it”, when I needed it most! Thank you, Aleksandra Tesanovic, Shalu (Privender) Saini, Rita Priori, Helga Steinmann, Helen Schonenberg, Mary-Ann Pepers, Boris De Ruyter, Joyca Lacroix, Ted van Groningen, Timon Grob, Rene Aarnink, Joanneke Groen, Stefan Pfundtner, Tim Weysen, Karin de Rijke and my close family and friends. 🙏 🙏 A special thank to Mary-Ann Pepers for the logo and brand design. 🙏 Today marks the start of a very exciting journey for me! I am wishing you a very Happy Labor Day!

98

57 commentaren

"𝘛𝘩𝘦 𝘣𝘦𝘴𝘵-𝘳𝘢𝘵𝘦𝘥 𝘴𝘦𝘴𝘴𝘪𝘰𝘯" ⭐⭐⭐⭐⭐ "𝘐 𝘧𝘦𝘭𝘵 𝘭𝘪𝘬𝘦 𝘢 𝘳𝘰𝘤𝘬𝘴𝘵𝘢𝘳" 🎙️ These are just some reactions to 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀 𝗼𝗻 𝗦𝘁𝗮𝗴𝗲 at the VIB Seminar. The great news? In 2025, we’re back to train six talented scientists to pitch their groundbreaking research! 𝗪𝗵𝗮𝘁 𝗶𝘀 𝘁𝗵𝗲 𝗩𝗜𝗕 𝗦𝗲𝗺𝗶𝗻𝗮𝗿? It’s a two-day event where all VIB researchers and staff discover the latest in computational biology, AI, mental health, and sustainability. 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀 𝗼𝗻 𝗦𝘁𝗮𝗴𝗲? On Day 2, six scientists take the stage to present their cutting-edge research in just 8 minutes, plenary, in front of an audience of 7️⃣0️⃣0️⃣ people! 𝗔𝗻𝗱 The Floor is Yours? For the next edition, on April 24–25, 2025, we’ll once again prepare these speakers to deliver performances that leave a lasting impression. The goal? To make their research crystal clear and unforgettable for everyone in the room. 𝗗𝗼𝗲𝘀 𝗶𝘁 𝘄𝗼𝗿𝗸? Absolutely. Every edition of Scientists on Stage is rated 𝘵𝘩𝘦 𝘣𝘦𝘴𝘵 𝘴𝘦𝘴𝘴𝘪𝘰𝘯 𝘰𝘧 𝘵𝘩𝘦 𝘴𝘦𝘮𝘪𝘯𝘢𝘳. Years later, people still talk about the presentations they’ve seen—like Antonella Fioravanti’s "anthrax letter" talk. In fact, even those who weren’t there have heard about it! (Read the full story 👉 https://lnkd.in/gAW2dMTn) 🙏 A big thank you to VIB for entrusting your researchers to us once again. 2️⃣0️⃣2️⃣5️⃣ is shaping up to be a truly magical year! 🌟 (Want to learn to pitch your research and shine on the stage? Check out our training https://lnkd.in/gtpz4Bcy) #ScienceCommunication #PresentWithImpact #VIBSeminar2025 VIB PostDocs

17

1 commentaar

We recently made a guest appearance on the #radiopharmaceutical podcast of Future Affordable Sustainable Therapies (FAST) 🎧 Listen to the podcast on daily applications of nuclear medicine (in Dutch) via the link in the comments. Below the highlights, questions and talking points for our English-speaking audience. In the podcast you will hear a nuclear medicine physician, a patient, and our team member Tessa Aminetzah discuss the fundamentals and opportunities of radiopharmaceuticals. But most importantly, it will give you a chance to see through the eyes of a patient who underwent radioligand therapy with Lutetium-177. The fundamentals of radiopharmaceuticals: - How radiation is used as medicine - Diagnostics vs treatment - Radiotherapy vs targeted medical isotopes - PSMA targeted therapy - Better cancer survival with targeted therapy Radiopharmaceuticals in drug development: - The use of radionuclides in drug development research (TRACER) - The use of microdosing studies and the benefits: early in-patient studies and fewer animal studies (TRACER) - Faster go/no-go decision-making based on Proof of Concept and faster bench to bedside for new medicines (TRACER) The patient's perspective: - The patient participated in a successful PSMA clinical trial, where in 6 months (4 treatments) his metastases were virtually gone - The patient experienced no side effects - PSA value went from 6 to 0.06 - What such a treatment looks like regarding staying in the hospital (from 24 hours eventually to 6) Use and availability of treatments: - Theragnostics, how the same targets can be used for diagnostic and treatment - Expectation of when this treatment will become more widely available in the Netherlands: from the beginning of next year - Comparison of this new treatment with alternatives (hormonal treatment, surgery and external beam radiation, and chemotherapy) The Netherlands & radiopharmaceuticals: - Where does the Netherlands stand in nuclear medicine? - The reactor in Petten produces 30-40% of medical isotopes for everyone in the world! - Nationwide there is an expected growth of 10% in diagnostics and an expected fivefold increase for treatment in the next 10 years A look into the future for radiopharmaceuticals: - For what indications can radiopharma enable treatment in the future? - Current status of radiopharmaceuticals among drug developers (TRACER) - The investments needed to further roll out the potential of radiopharmaceuticals #RadioPharma #RadioPharmaceuticals #NuclearMedicine #ProstateCancer

43

3 commentaren

Breaking Barriers: The Prime-Rose Project and Off-Label Drug Innovations 💥 Dive into the latest Vital Health Podcast episode, where Dr. Hans Gelderblom (Chair of Medical Oncology, Leiden University Medical Center) and Sahar Barjesteh van Waalwijk van Doorn-Khosrovani (Dutch National Payers Evaluation Committee) discuss the groundbreaking Prime-Rose Project. Discover how this innovative initiative is revolutionizing personalized medicine in Europe by balancing accessibility, affordability, and evidence-based treatments. Transforming healthcare, one step at a time. 👣 🎧 Listen now to learn more: https://lnkd.in/dWaR6BvE Picture: Sahar Barjesteh van Waalwijk van Doorn-Khosrovani #primerose #MissionCancer #HorizonEU #fightingcancer #medicine #personalisedmedicine #podcast

28

🗓️ We are delighted to announce our December MEGIN Masterclass "MEG in neuro-oncology: translating from cells to networks to clinical care" presented by guest speakers from Amsterdam UMC, Arjan Hillebrand, Linda Douw, Mona Zimmermann and Marike van Lingen. "In this masterclass, four experts working with MEG in brain tumor patients will outline the latest insights on the field. Their lecture spans from sharing an overview of what doing MEG in these patients entails, to the broader scientific scope of measuring brain activity in the neuro-oncological setting, to the state-of-the-art application of MEG in the clinical contexts of tumor growth and cognitive decline. On the data analysis side, they share how MEG can be used to interrogate local brain activity, to regional connectivity, to large-scale brain network topology, all within the scientific and clinical context of neuro-oncology." 💫 For more information and to register click here: https://lnkd.in/eWkyzU3A December 4, 2024 at 7am CDT | 8am EDT | 1pm GMT | 2pm CET | 3pm EET #MEG #neuroimaging #brainimaging #functionalmapping #thoughtleaders #masterclass

14

🛡️ Successful ImmuneHealthXL meeting 🛡️ The ImmuneHealthXL meeting took place at the NH Leeuwenhorst conference center with more than 70 participants. “By researching in a disease-overarching manner, we can unravel the underlying causes of immune-mediated inflammatory diseases (IMIDs) and improve the care of these patients.” The meeting was opened by Tale Sliedrecht who presented an overview and the ambitions of the ImmuneHealthXL initiative. Janneke Samsom introduced the research perspective of the initiative. She emphasised the heterogeneity of IMIDs and the importance of disease-overarching research is to enable personalised treatment for patients. Andreea Ioan-Facsinay from Genmab presented the industry perspective on the project and the opportunities antibodies can offer in the (personalised) treatment of autoimmunity. Patient involvement is an important part of the ImmuneHealthXL initiative and Maarten de Wit showed how patient involvement in scientific research can be achieved in a good way and how important collaboration is for scientific research. Rogier Thurlings explained on the clinicians’ perspective in the initiative. He emphasised the need for a platform like ImmuneHealthXL to bring together a network of researchers that can mean a lot to the IMID patients and by using best practices. The meeting concluded with the keynote presentation by Paul Peter Tak, MD PhD FMedSci. He shared his perspective on disease-overarching research. “This is the way to go, we should research immune-mediated inflammation across disease boundaries.” Thank you to all the participants and speakers who joined us today and for your support of the ImmuneHealthXL initiative! samenwerkende gezondheidsfondsen, Health~Holland, Hartstichting, ReumaNederland, Stichting MS Research Maag Lever Darm Stichting, Crohn & Colitis NL, Diabetes Fonds, Leiden University Medical Center, Radboud University Medical Centre Nijmegen, the Netherlands, UMCG, Sanquin, Lygature

56

1 commentaar

What if AI is just the new shiny toy and a passing trend? Will my business still be sustainable, or without AI, are we gone? That’s my takeaway and food for thought from the 'Future of Tech = AI for Impact' event at Google’s Amsterdam office. The event was organized by Kimberly Ofori, and I met lots of amazing people there. (Thanks for the effort, Kim😉) You know, AI has been around for decades and has gone through multiple hype cycles. You might’ve heard the term 'AI winter.' It was first used in 1984 by two AI researchers who experienced the AI winter of the '70s. We all remember the hype around the metaverse and blockchain, but AI has literally had several hype cycles over the past 50 years. I have my reasons to believe this time is different — the general public is using AI in their daily routines. But I think all founders, like myself, should still consider this risk and design their business models accordingly. I believe generative AI should remains a tool to create value for our customers. If there isn’t any AI, something else should solve our customers' problems. Their problem isn’t AI, and AI is just a tool that helps them solve it. Don’t use AI as the core solution to your customer’s problem. What’s your opinion? #StartupLife #entrepreneurship #ai

29

🚀 Exciting News: Unveiling Matrix Groundbreaking New Facility at VU! We are thrilled to announce that Matrix Innovation Centers - office and laboratory space for deep tech entrepreneurs in Amsterdam will open its newest building on the Vrije Universiteit Amsterdam (VU Amsterdam) Campus in mid-2027, marking a significant milestone for the city’s entrepreneurial and scientific community. Located at the corner of De Boelelaan and Korte Mahlerlaan, this state-of-the-art Innovation Centre will be a hub for start-ups, scale-ups, and external companies specializing in Life Sciences, Medtech, and AI. At Amsterdam Chemistry Network, we are especially proud to see this consolidation, as Vrije Universiteit Amsterdam (VU Amsterdam), one of our board members, continues to foster collaboration between universities and industry through cutting-edge facilities like this. The Demonstrator Lab VU will also have a prominent space in this new building, further driving research and innovation. Matrix Innovation Centers - office and laboratory space for deep tech entrepreneurs in Amsterdam currently operates 7 Innovation Centres at the Amsterdam Science Park, hosting over 100 companies. With this new addition, the goal is to continue boosting entrepreneurship, valorization, and cooperation between academia and industry, supporting the growth of start-up and scale-up communities in Amsterdam. 👏 A huge congratulations to Vrije Universiteit Amsterdam (VU Amsterdam), Amsterdam UMC, and the City of Amsterdam for their vision in promoting growth and innovation. We can't wait to see the impact this will have on the region’s landscape! #Innovation #Entrepreneurship #LifeSciences #Medtech #AI #Collaboration #Amsterdam #MatrixIC #VUAmsterdam #ACN https://lnkd.in/dnicjvpj

10

I'll be at a conference this Thursday diving into data-driven health advancements. Excited to share insights on digital transformation's impact on startups in the Dutch Life Sciences and Health MedTech sector. My research focuses on how Medtech startups are innovating in Industry 4.0. Drop me a DM if you'd like to connect! #HealthTech #DigitalTransformation #Startups #Industry4.0 #MedTech #DataDrivenHealth

1

🌟 Get ready to be inspired!! Join us on May 21st, 2024, from 3:00 PM to 6:00 PM at Loyens & Loeff for a community event that promises valuable insights for all Life Science, Biotech and MedTech enthusiasts. This event is tailor-made for: 🔬 Academic researchers in the Life Science domains 🚀 Biotech or MedTech start-ups/spin-offs on their journey towards clinical trials 🏢 Companies and stakeholders within the DCVA and RegMed XB network We have two exceptional speakers who will share their invaluable experience gained from navigating industrial partnerships within academic research, start-ups, and life sciences ventures. One of our speakers is Hans Schikan. Hans is a leading expert in the biopharmaceutical sector and brings over 30 years of development, commercial, and leadership experience. His biopharmaceutical career started at Organon, whereafter he continued his way to Genzyme and then at the Dutch start-up Prosensa to focus on the development of new medicines for e.g. Duchenne's disease. This brought him, among other things, to the trading floor of the American NASDAQ. Hans currently serves on several boards. He is Top Team member for the Dutch Topsector for Life Sciences & Health and a mentor for start-up companies with the Termeer Foundation. Don't miss out on this incredible opportunity to gather priceless knowledge and go home with practical tips and tricks to accelerate development through a partnership. Register now 👉 https://lnkd.in/erfMZvjW 🤝 #medtech #preclinical #preclinicalresearch #clinicaltrials #clinicaldevelopment #clinicalresearch #valorisation #lifescience #startups #research

26

🌟Consortium Member Spotlight: Utrecht University 🌟   As part of our ongoing series, we are thrilled to introduce the first organization in our consortium, Utrecht University. UU has long been at the forefront of developing innovative Health Technology Assessment (HTA) methods, and with its strong ties to both HTA and regulatory bodies, has played a key role in many pioneering initiatives that support the development of HTA. 💡 Significant contributions: 👉 Leadership of the H2020 HTx Project - Next Generation Health Technology Assessment and a key role in the IMI-GetReal project resulting in many publications and tools that advance HTA methods.  👉Collaboration with the Dutch national HTA body, Zorginstituut Nederland to ensure academic work is HTA focussed.  👉Leadership of SUSTAIN-HTA to ensure that work to identify, synthesize, and prioritize new HTA methods is driven by the needs of HTA bodies and leads to a learning platform that is sustainable long-term. 🎯 Within SUSTAIN-HTA, experts at Utrecht University will work towards 👉Establishing an expert forum of international scientific leaders in HTA.  👉Developing a horizon-scanning tool for identifying HTA needs and linking them with the latest methodologies.  👉Prioritizing innovative HTA tools that can address the needs of HTA organizations across Europe. Stay tuned as we continue to highlight the innovative work of our consortium members!  👉Find out more about our consortium here: https://lnkd.in/dmtx6UR5 #SUSTAIN_HTA #HorizonEurope #HealthTechnologyAssessment #HTA #Innovation

35

CardioVR is excited to showcase its innovative platform at the Demonstrator Lab Amsterdam Open House on December 12th. For those unfamiliar, Demonstrator Lab is the entrepreneurship laboratory of Vrije Universiteit Amsterdam where ideas transform into impactful ventures! 🌟 On this day, you can experience how we’re transforming patient education with immersive VR technology. Dive into our interactive demo, explore the human circulatory system, and see how CardioVR empowers patients to take control of their health. 💡 Join us to: 🎮 Step inside our VR world. 🧠 Discover the science and innovation behind CardioVR. 🌍 Learn how we’re reshaping chronic care management. Join us on this day and find the link in the comments! 🚀 #CardioVR #DemonstratorLab #Innovation #HealthTech #VirtualReality #PatientCare

46

4 commentaren

Proud to announce Lieve Naesens, from the Rega Institute for Medical Research in collaboration with CD3 acquired substantial Open Philanthropy funding to prepare against influenza pandemics. 👉 https://lnkd.in/eXgT9P88   Already prior to the COVID-19 pandemic, L. Naesens joined forces with the Centre for Drug Design and Discovery (CD3) to develop #influenza virus inhibitors that are well-suited for #pandemic preparedness. This resulted in the discovery of a mechanistically novel class of influenza polymerase inhibitors. Based on already acquired insight in their target and binding mode, we are fine-tuning this compound class towards the right candidate compound which could enter clinical development against influenza. The Open Philanthropy funding was granted through the Pandemic Antiviral Discovery Initiative. It is instrumental to realize the primary goal of our research, which is to develop antiviral strategies that can make a difference.   👉 www.rega.kuleuven.be 👉 www.padinitiative.com #Drugdiscovery #Flu

64

1 commentaar

Only one more week until the DCVA and RegMed XB #Valorization #Community Event ❗ Are you curious how scientific discoveries can be transformed into successful businesses? Register now via the link below. We hope to see you there! #Entrepreneurschip #Cardiovascular #Biotech #RegmedXB #DCVA #Healthcare #TranslationalResearch #LifeSciences #Innovation

1